Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Collier

Showing results (441-450 of 508) with videos related to

Pageof 51
Sort By:
The Journal of Infectious Diseases|August 22, 2020
Selective Decay of Intact HIV-1 Proviral DNA on Antiretroviral TherapyRajesh T Gandhi, Joshua C Cyktor, Ronald J Bosch, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 5, 2011
Neurocognitive impact of substance use in HIV infectionDesiree A Byrd, Robert P Fellows, Susan Morgello, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 6, 2012
Low cerebrospinal fluid concentrations of the nucleotide HIV reverse transcriptase inhibitor, tenofovirBrookie M Best, Scott L Letendre, Peter Koopmans, et al.
Psychosomatics|July 4, 2012
Health-related quality of life 'well-being' in HIV distal neuropathic pain is more strongly associated with depression severity than with pain intensityJohn R Keltner, Florin Vaida, Ronald J Ellis, et al.
Journal of Neurovirology|September 27, 2015
Long-term efavirenz use is associated with worse neurocognitive functioning in HIV-infected patientsQing Ma, Florin Vaida, Jenna Wong, et al.
Current HIV Research|December 18, 2015
Lower CSF Aβ is Associated with HAND in HIV-Infected Adults with a Family History of DementiaPariya L Fazeli, David J Moore, Donald R Franklin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 15, 2019
Diverse Human Immunodeficiency Virus-1 Drug Resistance Profiles at Screening for ACTG A5288: A Study of People Experiencing Virologic Failure on Second-line Antiretroviral Therapy in Resource-limited SettingsCarole L Wallis, Michael D Hughes, Justin Ritz, et al.
Journal of Neurovirology|September 18, 2014
Brain morphometric correlates of metabolic variables in HIV: the CHARTER studyS L Archibald, J A McCutchan, C Sanders, et al.
Journal of Virology|September 16, 2006
Selection on the human immunodeficiency virus type 1 proteome following primary infectionYi Liu, John McNevin, Jianhong Cao, et al.
Archives of Toxicology|August 28, 2013
Open letter to the European Commission: scientifically unfounded precaution drives European Commission's recommendations on EDC regulation, while defying common sense, well-established science, and risk assessment principlesDaniel Dietrich, Sonja von Aulock, H W J Marquardt, et al.
Pageof 51

Showing results (441-450 of 508) with videos related to

Sort By:
Pageof 51
The Journal of Infectious Diseases|August 22, 2020
Selective Decay of Intact HIV-1 Proviral DNA on Antiretroviral TherapyRajesh T Gandhi, Joshua C Cyktor, Ronald J Bosch, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 5, 2011
Neurocognitive impact of substance use in HIV infectionDesiree A Byrd, Robert P Fellows, Susan Morgello, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 6, 2012
Low cerebrospinal fluid concentrations of the nucleotide HIV reverse transcriptase inhibitor, tenofovirBrookie M Best, Scott L Letendre, Peter Koopmans, et al.
Psychosomatics|July 4, 2012
Health-related quality of life 'well-being' in HIV distal neuropathic pain is more strongly associated with depression severity than with pain intensityJohn R Keltner, Florin Vaida, Ronald J Ellis, et al.
Journal of Neurovirology|September 27, 2015
Long-term efavirenz use is associated with worse neurocognitive functioning in HIV-infected patientsQing Ma, Florin Vaida, Jenna Wong, et al.
Current HIV Research|December 18, 2015
Lower CSF Aβ is Associated with HAND in HIV-Infected Adults with a Family History of DementiaPariya L Fazeli, David J Moore, Donald R Franklin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 15, 2019
Diverse Human Immunodeficiency Virus-1 Drug Resistance Profiles at Screening for ACTG A5288: A Study of People Experiencing Virologic Failure on Second-line Antiretroviral Therapy in Resource-limited SettingsCarole L Wallis, Michael D Hughes, Justin Ritz, et al.
Journal of Neurovirology|September 18, 2014
Brain morphometric correlates of metabolic variables in HIV: the CHARTER studyS L Archibald, J A McCutchan, C Sanders, et al.
Journal of Virology|September 16, 2006
Selection on the human immunodeficiency virus type 1 proteome following primary infectionYi Liu, John McNevin, Jianhong Cao, et al.
Archives of Toxicology|August 28, 2013
Open letter to the European Commission: scientifically unfounded precaution drives European Commission's recommendations on EDC regulation, while defying common sense, well-established science, and risk assessment principlesDaniel Dietrich, Sonja von Aulock, H W J Marquardt, et al.
Pageof 51